Improving biosimilar uptake among rheumatologists

Biosimilar Development: Analyzing trends in biosimilar adoption

Vice President of Biosimilars Sonia Oskouei, PharmD, recently spoke with Anna Rose Welch, Chief Editor of Biosimilar Development, about the current state of biosimilar adoption among U.S. rheumatologists and explored some of the issues that are slowing broader uptake.